Penumbra Inc (PEN): R&D Expense
$89.77M
Year ended 2025-12-31
$92.25M
Trailing 12 months to 2026-06-30
+4.2%
3-year compound annual growth
-0.1%
5-year compound annual growth
+17.4%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $89.77M | -5.3% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $94.78M | +12.3% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $84.42M | +6.3% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $79.41M | -24.1% | 2025-02-18, From 2022-01-01 |
| 2021-12-31 | $104.55M | +16.1% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $90.05M | +74.1% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $51.72M | +43.0% | 2022-02-22, From 2019-01-01 |
| 2018-12-31 | $36.16M | +14.2% | 2021-02-23, From 2018-01-01 |
| 2017-12-31 | $31.66M | +32.6% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $23.88M | +32.4% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $18.03M | +15.7% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $15.57M | +10.6% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $14.08M | n/a | 2016-03-08, From 2013-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Penumbra Inc (PEN) | 2025-12-31 | $89.77M | -5.3% |
| Haemonetics Corp (HAE) | 2026-03-28 | $59.77M | -4.7% |
| Merit Medical Systems Inc (MMSI) | 2025-12-31 | $97.35M | +11.3% |
| Integra Lifesciences Holdings Corp (IART) | 2025-12-31 | $98.97M | -14.2% |
| Embecta Corp. (EMBC) | 2025-09-30 | $37.30M | -52.7% |
| Tandem Diabetes Care Inc (TNDM) | 2025-12-31 | $193.11M | -2.9% |
| Teleflex Inc (TFX) | 2025-12-31 | $144.78M | +32.8% |
| Inspire Medical Systems, Inc. (INSP) | 2025-12-31 | $103.17M | -9.6% |
| ICU Medical Inc (ICUI) | 2025-12-31 | $87.50M | -1.3% |
Compare PEN, HAE, MMSI, IART side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗